Finance

Lists
ALK-B:CPH
ALK-Abello A/S
227,40 DKK
-0,35%
(-0,80) 1D
9-окт., 17:00:00 GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for ALK-B...
Open
228,20 DKK
High
229,80 DKK
Low
224,80 DKK
Mkt. cap
46,06 млд
Avg. vol.
218,86 миң
Volume
243,21 миң
52-wk high
271,40 DKK
52-wk low
191,80 DKK
Shares outstanding
202,57 млн
No. of employees
3 миң
Open
228,20 DKK
High
229,80 DKK
Low
224,80 DKK
Mkt. cap
46,06 млд
Avg. vol.
218,86 миң
Volume
243,21 миң
52-wk high
271,40 DKK
52-wk low
191,80 DKK
Shares outstanding
202,57 млн
No. of employees
3 миң
News stories
From web sources and news partners
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2,77 миң
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitealk.net
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,53 млд
1,73 млд
1,77 млд
1,80 млд
Cost of goods sold
487,00 млн
543,00 млн
543,00 млн
600,00 млн
Cost of revenue
487,00 млн
543,00 млн
543,00 млн
600,00 млн
Research and development expenses
145,00 млн
189,00 млн
151,00 млн
168,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
475,00 млн
605,00 млн
507,00 млн
582,00 млн
Operating expense
620,00 млн
793,00 млн
658,00 млн
750,00 млн
Total operating expenses
1,11 млд
1,34 млд
1,20 млд
1,35 млд
Operating income
423,00 млн
397,00 млн
570,00 млн
445,00 млн
Other non operating income
-
-
-
-
EBT including unusual items
419,00 млн
393,00 млн
583,00 млн
452,00 млн
EBT excluding unusual items
419,00 млн
403,00 млн
583,00 млн
452,00 млн
Income tax expense
105,00 млн
127,00 млн
146,00 млн
113,00 млн
Effective tax rate
25,06%
32,32%
25,04%
25,00%
Other operating expenses
-
-1,00 млн
-
-
Net income
314,00 млн
266,00 млн
437,00 млн
339,00 млн
Net profit margin
20,52%
15,35%
24,68%
18,89%
Earnings per share
1,40
1,20
2,00
1,50
Interest and investment income
-
28,00 млн
13,00 млн
7,00 млн
Interest expense
-4,00 млн
-6,00 млн
-
-
Net interest expenses
-4,00 млн
22,00 млн
13,00 млн
7,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
510,00 млн
400,00 млн
654,00 млн
531,00 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору